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Abstract
 
We generated a mouse line in which the src homology 2 domain–bearing protein tyrosine
phosphatase (SHP)-2 binding site of gp130, tyrosine 759, was mutated to phenylalanine
(
 
gp130
 
F759/F759
 
). The 
 
gp130
 
F759/F759
 
 mice developed rheumatoid arthritis (RA)-like joint dis-
ease. The disease was accompanied by autoantibody production and accumulated memory/ac-
tivated T cells and myeloid cells. Before the disease onset, the T cells were hyperresponsive and
thymic selection and peripheral clonal deletion were impaired. The inhibitory effect of IL-6 on
Fas ligand expression during activation-induced cell death (AICD) was augmented in
 
gp130
 
F759/F759
 
 T cells in a manner dependent on the tyrosine residues of gp130 required for sig-
nal transducer and activator of transcription 3 activation. Finally, we showed that disease devel-
opment was dependent on lymphocytes. These results provide evidence that a point mutation
of a cytokine receptor has the potential to induce autoimmune disease.
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Introduction
 
Rheumatoid arthritis (RA)
 
*
 
 is a frequent autoimmune dis-
order; however, its etiology and pathogenesis are still not
completely understood (1, 2). Genetic background and en-
vironmental factors, such as bacterial or viral infection, are
thought to be involved in its onset. The genetic linkage of
RA to an MHC class II molecule (HLA-DR) and the infil-
tration of T cells into the synovium of RA joints suggest
that T cells are involved in the abnormal immune responses
associated with RA (1). Proinflammatory cytokines, such as
TNF-
 
 
 
, IL-1, and IL-6 are thought to play crucial roles in
the pathology of RA and autoimmune diseases (3–5). Sev-
eral engineered mutant mice that spontaneously develop
arthritis have been reported. Analyses of the K/BxN TCR
transgenic mouse showed that an autoantibody specific to a
ubiquitous molecule can induce an organ-specific au-
toimmune disease (2, 6, 7). The HTLV-1 transgenic
mouse is an animal model of arthritis that is triggered by vi-
 
ral infection (8). TNF-
 
 
 
 transgenic mice and TNF AU-rich
elements-deficient mice revealed that TNF-
 
 
 
 is a pivotal
cytokine for the induction of other proinflammatory cy-
tokines and for the abnormal growth of synovial cells (9,
10). IL-1
 
 
 
 transgenic mice (11) and gene targeting of an
IL-1 receptor antagonist (12) indicated that the increased
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Cytokine Receptor Mutation Induces Autoimmune Arthritis
 
activity of a proinflammatory cytokine (IL-1) results in ar-
thritis. The generation of RA-like joint diseases in a variety
of engineered mutant mice may reflect the heterogeneity of
human RA or the complicated mechanisms underlying the
disease.
IL-6, which was originally identified as a B cell differen-
tiation factor (13, 14), is now known to be a multifunc-
tional cytokine that regulates the immune response, he-
matopoiesis, the acute phase response, and inflammation (4,
15). The first suggestion that IL-6 is involved in autoim-
munity came from the finding that it is produced by cardiac
myxoma cells, and patients with cardiac myxoma fre-
quently show autoimmune symptoms (16). Since then,
several pieces of evidence have been reported that suggest
the involvement of IL-6 in autoimmune diseases, including
RA (4, 17). Furthermore, IL-6 is required for experimen-
tally induced autoimmune diseases or autoimmunity, in-
cluding type II collagen- and antigen-induced arthritis (18–
20), myelin oligodendrocyte protein-induced experimental
autoimmune encephalomyelitis (21, 22), and pristane-
induced autoantibody production (23). These results sug-
gest that IL-6–dependent signaling pathways are involved in
the pathogenesis of these experimentally induced autoim-
mune diseases. However, it is unknown whether IL-6 and its
receptor system are involved in the pathogenesis of sponta-
neously occurring autoimmune diseases. The IL-6 receptor
consists of an 
 
 
 
 chain and the subunit gp130. gp130 is
shared by the receptors for IL-6 family cytokines, including
leukemia inhibitory factor, ciliary neurotropic factor, on-
costatin M, IL-11, and cardiotropin-1 (24). Binding of one
of these cytokines to its receptor and gp130 activates JAK-1,
JAK-2, and TYK-2, which phosphorylate tyrosine resi-
dues in the cytoplasmic domain of gp130. The transcrip-
tion factor signal transducer and activator of transcription
(STAT)-3 is recruited to the phosphorylated tyrosine resi-
dues in the YXXQ motif of gp130, where it is activated
and dimerized, and subsequently enters the nucleus and
regulates gene expression (24, 25). The src homology 2 do-
main–bearing protein tyrosine phosphatase (SHP)-2, is re-
cruited to the phosphorylated tyrosine residue Y759 in
gp130, where it becomes activated and forms a complex
with the adaptor docking proteins, Gab1 and Gab2, leading
to activation of the Ras–MAP kinase pathway (26). Several
experiments in vitro have indicated that the SHP-2– and
STAT-3–mediated signal-transduction pathways that are
initiated through gp130 are involved in growth, differenti-
ation, and gene expression in various cell lines (24, 25, 27,
28). SHP-2–mediated ERK mitogen-activated protein
(MAP) kinase activation has been suggested to play nega-
tive roles in STAT-3–mediated biological responses (29,
30). Tyrosine residue Y759 also provides the binding site
for the suppressor of cytokine signaling (SOCS)-3 protein,
which negatively regulates the gp130 signals (31, 32). Re-
cently, we generated a series of knock-in mouse lines in
which the gp130-mediated SHP-2 or STAT-3 signals are
selectively disrupted. To make the SHP-2 signal-deficient
mice (
 
gp130
 
F759/F759
 
), we mutated Y759 of gp130 to phe-
nylalanine (F759). The 
 
gp130
 
F759/F759
 
 mice are born normal
 
but develop splenomegaly, lymphadenopathy, and an en-
hanced acute phase reaction. In contrast, the STAT-3 sig-
nal-deficient mice (
 
gp130
 
FXXQ/FXXQ
 
) die perinatally, as do
gp130-deficient mice (
 
gp130
 
D/D
 
). The embryonic fibro-
blasts from the 
 
gp130
 
F759/F759
 
 mice show a severe reduction
in ERK MAP kinase activation and prolonged STAT-3 ac-
tivation after gp130 stimulation. The 
 
gp130
 
F759/F759
 
 mice
show increased production of Th1-type cytokines and Igs
of the IgG2a and IgG2b classes, while these molecules are
decreased in the 
 
gp130
 
FXXQ/FXXQ
 
 immune system. These
results indicate that the SHP-2–mediated or Y759-depen-
dent signals negatively regulate the biological responses
elicited by the STAT-3–mediated signals in vivo, and that
the balance of positive and negative signals generated
through gp130 is skewed or shifted to positive STAT-3
signaling in 
 
gp130
 
F759/F759
 
 mice (33). Here we report that
 
gp130
 
F759/F759
 
 mice spontaneously developed arthritis in a
manner dependent on lymphocytes accompanied by au-
toantibody production and T cell abnormalities at 
 
 
 
1 y of
age. The 
 
gp130
 
F759/F759
 
 mouse is thus a unique animal
model in which a point mutation in a cytokine receptor re-
sults in a RA-like autoimmune disease.
 
Materials and Methods
 
Animals.
 
The establishment of the 
 
gp130
 
F759/F759
 
 knock-in
mouse line was described previously (33). Heterozygous mice of
a 129/C57BL/6 mixed background were intercrossed to obtain
homozygous knock-in mice in the F3 generation, which were
used for the studies described in this paper except for generat-
ing 
 
gp130
 
F759/F759 
 
recombination activation gene (
 
RAG
 
)-
 
2
 
 
 
/
 
 
 
mouse. 
 
gp130
 
F759/F759
 
RAG-2
 
 
 
/
 
 
 
 mouse was generated by cross-
ing 
 
gp130
 
F759/F759
 
 mouse with 
 
RAG-2
 
–deficient mouse of
129S6/C57BL/6F1 background. To make a F1 generation of
 
RAG-2
 
–deficient mouse in a C57BL/6 and 129S6/SvEv back-
ground, we obtained 
 
RAG-2
 
–deficient mouse, that had been
backcrossed to C57BL/6 eight times, and 
 
RAG-2
 
–deficient
mouse with a 129S6/SvEv background from M. Itoh (Laboratory
of Immunology, Central Institute for Experimental Animals,
Kanagawa, Japan) and Taconic, respectively. To obtain lympho-
cytes from 
 
gp130
 
FXXQ/FXXQ
 
 mice, which die as neonates, we
reconstituted lethally irradiated mice with liver cells from
 
gp130
 
FXXQ/FXXQ
 
 fetuses that were harvested at 14.5 d after coitus,
as described previously (reconstituted mice; reference 33). These
mice were kept at the Institute of Experimental Animal Sciences
at Osaka University Medical School.
 
Detection of Igs and Autoantibodies in Sera.
 
To analyze the rela-
tionship between the serum antibody levels including autoanti-
bodies, severity of the arthritis, and sex differences, we collected
sera from 
 
gp130 
 
F759/F759
 
 mice with arthritis and 
 
gp130 
 
WT/WT
 
mice of both sexes at 11–12 mo old (male 
 
gp130 
 
F759/F759
 
, 
 
n
 
 
 
  
 
14;
female 
 
gp130 
 
F759/F759
 
, 
 
n 
 
  
 
17; male 
 
gp130 
 
WT/WT
 
, 
 
n
 
 
 
  
 
8; and fe-
male 
 
gp130 
 
WT/WT
 
, 
 
n
 
 
 
  
 
8). Serum levels of total Igs were deter-
mined by an isotype-specific ELISA as described previously (34).
Rheumatoid factor (RF) for mouse Ig of both IgM and IgG
classes, anti-dsDNA, and anti–ssDNA antibodies were measured
using commercial ELISA kits (Shibayagi, Japan). An ELISA kit for
anti-nRNP antibody was purchased from Alpha Diagnostic. To
detect RF, 100 
 
 
 
l of 200-fold diluted serum was added to each
well of the ELISA plate precoated with Fc fragments of mouse
IgG. The plates were incubated for 2 h and washed three times 
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with washing buffer. Then, horseradish peroxidase–labeled goat
anti–mouse IgG, which was deprived of anti–mouse Fc antibodies
by extensive absorption, was added. After 2 h incubation, the
plates were washed three times, substrate was added and the ab-
sorbance at 450 nm was measured by the microplate reader.
 
Clinical Assessment of Arthritis.
 
The mice were assessed by two
independent observers for signs of arthritis: redness, swelling, and
restriction of mobility. The severity of the arthritis was based on
five signs, which were each assessed bilaterally: (1) swelling of
digits of the forelimb; (2) swelling of the footpad; (3) swelling of
the ankle; (4) restriction of mobility of the wrist joint; and (5) re-
striction of mobility of the ankle joint. The severity of the arthri-
tis was graded on a scale of 0–2 for each of the five conditions as
follows: 0 (no change); 1 (mild change); and 2 (severe change).
The severity score shown in Fig. 1 b is a sum of the scores for the
five signs, assessed bilaterally, to give a possible maximum of 20
points for each mouse. The incidence was expressed as the per-
centage of mice that showed visible arthritis.
 
Radiology and Histology.
 
X-ray photographs of the bones
were taken using a SOFTEX CMB-2 (SOFTEX Co., Ltd.) and
Fuji Film. For the histologic examination, joints were fixed in
4% paraformaldehyde, decalcified in 10% EDTA-4Na, and em-
bedded in paraffin. Sections were stained with H&E. For the
tartrate-resistant acid phosphatase (TRAP) staining, naphthol
AS-BI phosphate (Sigma-Aldrich) was used according to the
manufacturer’s instructions, and the sections were counter-
stained with hematoxylin.
 
Quantitative Analysis of Gene Expression.
 
Total RNA was iso-
lated from the joints or activated T cells using sepasol–RNA I
(Nakarai Tesque), or RNeasy mini kit (QIAGEN). For RT-
PCR analysis, 3–5 
 
 
 
g of total RNA was digested with RN-
ase-free DNaseI. First-strand cDNAs were synthesized using
Oligo(dT)
 
12–18
 
 Primer and SuperScriptII RNaseH
 
  
 
reverse tran-
scriptase (GIBCO BRL). To detect corresponding cytokine
mRNAs by RT-PCR, specific primers and probes reported pre-
viously were used (35). The specific primer pairs for FasL and
SOCS-3 were as follows: FasL 5
 
 
 
-CTGGGTTGTACTTCGT-
GTATTCCA-3
 
 
 
 and 5
 
 
 
-TCCTCCATTAGCACCAGATCCT-
3
 
 
 
 and SOCS-3: 5
 
 
 
-GCGAGAAGATTCCGCTGGTA-3
 
 
 
 and
5
 
 
 
-CGTTGACAGTCTTCCGACAAA-3
 
 
 
. PCR reactions were
performed in the GeneAmp 5700 Sequence Detection System
(Applied Biosystems). The relative amounts of transcripts were
normalized to the HPRT transcript.
 
 FACS
 
®
 
 Analysis.
 
Flow cytometry analysis was performed as
described previously (36), and analyzed using a FACSCalibur™
flow cytometer (Becton Dickinson). mAbs used are as follows:
FITC-anti-IgM (AM/3); FITC-anti-CD44 (IM7); FITC-anti-
CD25 (PC61); FITC-anti-Gr-1 (RB6–8C5); FITC-anti-TCR-
 
 
 
for HY (T3.70, a gift from Y. Takahama, RIKEN Research Cen-
ter for Allergy and Immunology, Tokushima, Japan); PE-anti-IgD
(11–26c); PE-anti-CD62L (MEL14); PE-anti-CD69 (H1.2F3);
PE-anti-Syndecan-1 (281–2); Quantum Red-anti-CD8
 
 
 
 (53–
6.7); or APC-anti-CD4 (CT-CD4), APC-anti-CD11b (M1/70),
and APC-anti-CD45R (RA3–6B2). To avoid the contamination
of peripheral T cells, the thymus from old mice was carefully taken
out after removal of the parathymic lymph nodes. Furthermore,
we examined a part of the sample histologically.
 
Cell Proliferation Assay.
 
Thymocytes or lymph node cells
were cultured at 5 
 
 
 
 10
 
5
 
 cells per well or 2 
 
 
 
 10
 
5
 
 cells per well,
respectively, in 96-well plates for 48 or 72 h, in RPMI 1640 con-
taining 10% FCS and 50 
 
 
 
M 2-mercaptoethanol, in the presence
of various concentrations of a hamster anti–mouse CD3
 
 
 
 anti-
body (clone 145–2C11). 
 
3
 
[H]thymidine (0.5 
 
 
 
Ci per well) was
pulsed for the last 6 h of incubation, and incorporation was mea-
sured with a micro 
 
 
 
-counter.
 
Analysis of Thymic Selection Using Anti-HY TCR Transgenic
Mice.
 
Anti-HY TCR transgenic mice were purchased from
Taconic and mated with 
 
gp130
 
F759/F759
 
 mice to obtain the F1
generation. Anti-HY TCR gene expression was detected by
staining peripheral blood cells with the anticlonotypic antibody,
FITC-T3.70. F1 mice were intercrossed to obtain anti-HY
TCR
 
 
 
 
 
gp130
 
WT/WT
 
 and anti-HY TCR
 
 
 
 gp130F759/F759 mice of
both sexes. Thymocytes of 6–8-wk-old mice were stained with
FITC-T3.70, PE-anti-CD4 (RM4–5), Quantum Red-anti-CD8 ,
and T3.70  thymocytes were analyzed with a FACSCalibur™
flow cytometer.
Clonal Deletion In Vivo by Staphylococcal Enterotoxin B. Staph-
ylococcal enterotoxin B (SEB) (100  g) (Toxin Technology) was
injected intraperitoneally into 6-wk-old mice on day 0. T cell
subsets in the peripheral blood were analyzed by flow cytometry
on days 0, 3, 7, and 14. Cells were stained with FITC-anti-
V 8.1/8.2 (clone MR5–2) or FITC-anti-V 6 (clone RR4–7),
Quantum Red-anti-CD8  and APC-anti-CD4.
Induction and Analysis of Apoptosis. Lymph nodes T cells were
negatively enriched (purity   96%) using magnetic beads conju-
gated with anti-MHC class II antibody and a Midi MACS® col-
umn (Miltenyi Biotec). Purified T cells (5   105 cells per millili-
ter) were stimulated with plate-immobilized 5  g/ml anti-CD3
antibody, 2  g/ml anti-CD28 antibody (clone 37.51; BD Phar-
Mingen), and 50 U/ml rIL-2 for 48 h. The cells were harvested,
washed, and replated at 3   105 cells per milliliter for a further
48 h in the presence of rIL-2 to prepare the activated T cells for
activation-induced cell death (AICD) induction. They were then
harvested, and the dead cells were removed using Histopaque
1083 (Sigma-Aldrich) following the manufacturer’s instructions.
To induce AICD, the viable activated T cells were cultured at 106
cells per milliliter with plate-immobilized anti-CD3 in the pres-
ence or absence of 20 ng/ml IL-6. 2 h later, some T cells were
harvested and the total RNA was isolated using an RNeasy Mini
kit (QIAGEN) for quantitative RT-PCR as described above. 8
and 20 h later, a part of T cell culture was used for staining with
the following antibodies: FITC-anti-CD4 (RM4–4); PE-anti-
FasL (MFL3; BD PharMingen); 7-AAD; and Cy5-AnnexinV, and
analyzed with a FACSCalibur™ flow cytometer.
Western Blot Analysis. Activated T cells for AICD were stim-
ulated with 20 ng/ml IL-6 at 37 C for 30, 60, 120, and 180 min.
Cell lysis and Western blot analysis were performed as described
previously (33). Anti–phospho-JAK-1 (Biosource), anti-phos-
pho-STAT-3 (New England Biolabs), and anti–STAT-3 anti-
bodies (New England Biolabs) were used in this study.
Statistical Analysis. Statistical analyses for growth responses,
numbers of T3.70 CD8  thymocytes, and SEB-induced clonal
deletion were performed by Student’s t test. Serum levels of Igs
and autoantibodies in male and female gp130F759/F759 mice and
quantitative analysis of cytokine mRNA expression were ana-
lyzed by Mann-Whitney U test. Correlation between serum au-
toantibody levels and severity scores was examined using Spear-
man’s rank correlation. P   0.05 is thought as significant.
Results
Spontaneous Development of Arthritis in gp130F759/F759
Mice. By as early as 8 mo, the gp130F759/F759 mice showed
swelling and redness of the paws and limited mobility of
the ankle or wrist joints (Fig. 1 d). Neither wild-type nor982 Cytokine Receptor Mutation Induces Autoimmune Arthritis
gp130WT/F759 littermates showed these symptoms (Fig. 1 c).
The incidence of arthritis was  45% in the gp130F759/F759
mice at 11–15 mo of age and reached 100% in those older
than 16 mo (Fig. 1 a). The severity scores, which were as-
sessed by the criteria defined in Materials and Methods,
were higher in older mice (Fig. 1 b). In addition, the larger
joints, such as the elbows and knees, were affected sym-
metrically in many diseased mice and became rigid. Thus,
the arthritis observed in gp130F759/F759 mice was chronic
and progressive. The gp130F759/F759 mice backcrossed to
C57BL/6 eight times developed essentially similar arthritis
as  gp130F759/F759 mice of a 129/C57BL/6 mixed back-
ground that we used in this study (unpublished data).
 There was no significant difference in the final inci-
dence between males and females; however, in females the
onset of arthritis tended to be earlier (unpublished data).
Actually, when the severity scores of mice with arthritis at
ages 11–12 mo old were analyzed, the score was signifi-
cantly higher in females than males; (average score   SEM:
female, 13.5   1.3, n   17; male, 9.6   0.9, n   14; P  
0.05), suggesting that the hormonal environment somehow
affects the severity of arthritis in gp130F759/F759 mice. In his-
tologic examination, the gp130F759/F759 mice showed severe
synovitis with destructive changes at multiple joints.
Representative histology results are shown in Fig. 1, i–p.
In the ankle joint of gp130F759/F759 mice, marked prolifera-
tion of the synovium with pannus formation accompanied
by the infiltration of inflammatory cells, predominantly
neutrophils (Fig. 1 j, inset), with fibrin deposits and severe
bone destruction were observed (Fig. 1 j, and control, i).
At the site of bone erosion, activated osteoclasts, which
were identified as TRAP  multinucleated cells, were ob-
served (Fig. 1, o and p). The knees were also affected (Fig.
1 l and control, k). In the mice with rigid ankles and toes, a
severe narrowing of joint spaces and ankylosis were ob-
served (Fig. 1 n and control, m).
In radiologic examinations, generalized osteoporosis and
marked joint destruction were noted in all limbs. The pha-
langeal and tarsal bones were destroyed, and prominent
bone fusions and reactive sclerotic changes in the tarsal
bones were observed (Fig. 1 f, and control, e). In addition,
severe joint destruction and ankylosis were also observed in
the larger bilateral joints such as the ankles, knees, and hips
(Fig. 1 h, and control, g). All these clinical, histologic, and
radiologic findings in the gp130F759/F759 mice resemble
those of human RA, although some differences were ob-
served, such as the relatively small number of infiltrated
lymphocytes and plasma cells in the mice. Quantitative
Figure 1. Development of spontaneous arthritis in gp130F759/F759 mice. (a) Incidence of arthritis in gp130F759/F759 mice of three age groups. Each joint
of gp130WT/WT (male n   26, female n   23) and gp130F759/F759 (male n   29, female n   15) mice was regularly examined and the severity was scored
according to a set of defined criteria (see Materials and Methods). White and black bars indicate the incidence of arthritis in gp130WT/WT and gp130F759/F759
mice of each age group, respectively. (b) Relationship between age and severity of arthritis in gp130F759/F759 (black circle: male n   29, female n   15)
and control gp130WT/WT (white square, male n   26, female n   23) mice. (c) Hindlimb of an 11-mo-old gp130WT/WT mouse. (d) Swelling and redness
of the hindlimb of an 11-mo-old gp130F759/F759 mouse. (e and f) Radiologic analysis of hindlimbs from gp130WT/WT (e) and gp130F759/F759 (f) mice. Rep-
resentative cases (18 mo old) from the radiological analysis of 18 mice with arthritis are shown. (g and h) Control gp130WT/F759 mouse (g) and ankylosis of
the large joints of a gp130F759/F759 mouse (h) (28 mo old). (i–p) Histological analyses of H&E-stained sections of joints. Ankle joints of gp130WT/WT (i) and
gp130F759/F759 (j) mice. Inset in (j) shows infiltration of neutrophils in the synovium in larger magnification. Knee joints of gp130WT/WT (k) and gp130F759/F759
(l) mice. Ankylotic ankle joint of gp130F759/F759 (n) mouse, whose X-ray photographs are shown in (h), and a control gp130WT/F759 (m) mouse. (o) Pannus
formation and activated osteoclasts in the ankle joint of a gp130F759/F759 mouse. (p) TRAP staining of a serial section from the section used in (o) with he-
matoxylin counter staining. Representative cases from the histological analysis of gp130F759/F759 mice with arthritis (n   18) are shown.983 Atsumi et al.
RT-PCR analysis of cytokine transcripts in the joints of
the gp130F759/F759 mice revealed significantly higher tran-
scriptional levels of IL-6 (fold   SEM; 24   9, P   0.05)
than in controls. Although it was not statistically significant,
some cases of arthritis mice showed elevated transcriptional
levels of IL-1  (2.4   0.7), IL-10 (3.6   1.0), and TNF- 
(1.8   0.9). Thus, the balance of the local cytokine pro-
duction tended to become skewed toward a proinflamma-
tory status.
Autoantibody Production in gp130F759/F759 Mice. Sponta-
neous development of RA-like arthritis in gp130F759/F759
mice prompted us to examine autoantibody production of
mice with arthritis. At the age of 9 wk, the serum Ig levels
of all isotypes in the gp130F759/F759 Igs were similar to those
in wild-type littermates (33). However, at 11–12 mo of
age, serum Igs were slightly increased in gp130F759/F759
mice with arthritis. The serum levels of IgG1 (average
OD   SEM: male, gp130F759/F759, 0.37   0.01; gp130WT/WT,
0.31   0.02, P   0.05, female, gp130F759/F759, 0.40   0.01;
gp130WT/WT, 0.23   0.02, P    0.01) and IgA (male,
gp130F759/F759, 0.32   0.01; gp130WT/WT, 0.26   0.01, P  
0.01, female, gp130F759/F759, 0.33   0.01; gp130WT/WT,
0.26   0.02, P   0.01) were increased in both male and
female  gp130F759/F759. IgG2a in female (gp130F759/F759,
0.24   0.01; gp130WT/WT, 0.19   0.01, P   0.01) and
IgG2b in male (gp130F759/F759, 0.38   0.00; gp130WT/WT,
0.32   0.02, P   0.05) were a little bit increased.
 There was no significant difference in the increase of se-
rum Ig levels between male and female gp130F759/F759 mice
(unpublished data) except for IgG1 (male, 0.37   0.01; fe-
male, 0.40   0.01, P   0.05). More importantly, the 11–
12-mo-old  gp130F759/F759 mice produced significantly
higher levels of autoantibodies, such as RF of the IgG class,
anti–single-strand DNA (anti-ssDNA), anti–double-strand
DNA (anti-dsDNA), and anti-ribonuclear protein (anti-
nRNP) antibodies, all of which were significantly higher in
females than males: IgG-RF (average of OD   SEM for
males 0.10   0.03, and females 0.20   0.05, P   0.01),
anti-ssDNA antibody (0.33   0.14, and 1.40   0.27, P  
0.01), anti-dsDNA antibody (0.20   0.08 and 0.83  
0.18, P   0.01) and anti-nRNP antibody (0.88   0.11,
and 1.49   0.16, P   0.01) (Fig. 2). These results suggest
that the abnormal gp130 signals broke the homeostasis of
the immune system and elicited autoimmunity. However,
there were neither proteinuria nor pathological changes in
the kidney (unpublished data).
Then, we statistically examined the correlation between
the severity and the level of each autoantibody in females
and males. However, there was no correlation between
the level of each autoantibody and severity score. Some
gp130F759/F759 mice had sporadic elevation of the serum
IgM-RF, being not correlated with severity score (unpub-
lished data). We also examined the correlation between
the level of each autoantibody in males and females; IgG-
RF versus IgM-RF, IgG-RF versus anti-ssDNA, IgG-RF
versus anti-dsDNA, IgG-RF versus anti-nRNP, anti-
ssDNA versus anti-dsDNA, and anti-dsDNA versus anti-
nRNP. Among them, there were correlations in IgG-RF
versus anti-ssDNA (r   0.54, P   0.05), IgG-RF versus
anti-nRNP (r   0.67, P   0.01), and anti-ssDNA versus
anti-dsDNA (r   0.84, P   0.01) in females. In males,
only anti-ssDNA versus anti-dsDNA showed correlation
(r   0.99, P   0.01). These results suggest that the
hormonal environment affects the autoimmunity in
gp130F759/F759 mice.
Increase in Activated T Cells and Myeloid Cells in the Lym-
phoid Organs of gp130F759/F759 Mice. To understand the in-
volvement of the immune system in the arthritis of the
gp130F759/F759 mice, we first analyzed the cell populations
in their lymphoid organs compared with those of their
gp130F759/WT littermates. Analysis of the thymus of the dis-
eased mice revealed a lower frequency of CD4/CD8 dou-
ble-positive cells and a higher frequency of CD4/CD8
double-negative cells and CD4 or CD8 single-positive cells
than their gp130F759/WT littermates (Fig. 3 a). The popula-
tion of CD4/CD8 double-negative cells included IgMlo
Figure 2. Autoantibody production in gp130F759/F759 mice. Serum from 11–12-mo-old gp130F759/F759 mice with arthritis (n   31; 14 male, 17 female)
and their wild-type littermates (n   16; 8 male, 8 female) was assayed for the levels of autoantibodies by ELISA. White and black circles represent the se-
rum levels of antibody in individual gp130WT/WT and gp130F759/F759mouse, respectively. Horizontal bars represent the mean values of each group. Aster-
isks indicate significant differences by Mann-Whitney U test (*P   0.05; **P   0.01).984 Cytokine Receptor Mutation Induces Autoimmune Arthritis
IgDhi conventional B cells, CD45R Syndecan-1  plasma
cells, and CD11b  (Gr-1  and Gr-1  cells (Fig. 3 b and
unpublished data). These abnormalities of thymic popula-
tions expressing CD4 or CD8 were present to various de-
grees in 80% (16 out of 20) of the mice with arthritis. The
lower frequency of CD4/CD8 double-positive cells and
the higher frequency of CD4 or CD8 single-positive cells
in the thymus were unlikely to be due to the stress experi-
enced by the mice with arthritis, because these differences
began to be observed in gp130F759/F759 mice as young as 18
wk old, before the onset of the arthritis (unpublished data).
 In the lymph nodes of the gp130F759/F759 mice with ar-
thritis, the numbers of myeloid cells, especially Gr-1 
CD11b  cells (Fig. 3 c), were higher to various degrees.
Correlating with the level of increase in the number of
neutrophils, B cells were relatively fewer in the mice with
arthritis (unpublished data). The number of B-1 cells was
not higher in the spleens of the mice with arthritis. Al-
though the ratio of CD4 to CD8 T cells showed no consis-
tent changes, the CD62L CD44  naive T cell subset was
almost completely absent in the populations of both CD4 
and CD8  T cells (Fig. 3, e and f). Instead, the numbers
of CD62L CD44  memory/activated T cells and CD62L 
CD44  T cells were higher in the CD4  and CD8  T cell
populations, respectively. The activated status of the T cells
in the arthritic mice was further indicated by the higher
numbers of CD4  T cells expressing CD69 or CD25,
which are early activation markers (Fig. 3 d). The number
of CD8  T cells expressing CD69 or CD25, however, was
rarely higher in the arthritic mice (unpublished data).
These differences were also observed in the spleen, indicat-
ing that the peripheral T cells, especially the CD4  T cells,
were chronically activated in the gp130F759/F759 mice with
arthritis.
Hyperresponsiveness of Thymocytes and Lymph Node T Cells
in Young gp130F759/F759 Mice.  The flow cytometry analy-
sis indicated no abnormalities in the major population or
surface markers of lymphoid cells from gp130F759/F759 mice
younger than 12-wk-old (Fig. 4, a and b, top). However,
the anti-CD3 antibody-induced T cell growth responses
were much higher in the thymocytes and lymph node cells
of young gp130F759/F759 mice than in wild-type mice (Fig.
4, a and b, bottom), indicating that the functional abnor-
mality of the T cells was present in the gp130F759/F759 mice
even before disease onset.
Impairment of Thymic Negative Selection and Clonal Deletion
in the Peripheral T Cells of gp130F759/F759 Mice In Vivo.
Both central and peripheral tolerances play crucial roles in
maintaining self-tolerance (37, 38). We crossed gp130F759/F759
mice with anti–HY-TCR transgenic mice to examine the
effect of the gp130F759/F759 mutation on thymic selection
(39). In the female anti-HY-TCR   gp130F759/F759 thy-
mocytes, the frequency of CD8  cells was similar to anti-
HY-TCR  gp130WT/WT thymocytes (Fig. 5 a, top), indi-
cating that positive selection was not impaired. In the male
anti–HY-TCR  gp130F759/F759 thymocytes, a severe reduc-
tion in total cell number and CD4/CD8 double-positive
cells was observed, similar to that seen in anti-HY-TCR 
gp130WT/WT thymocytes, but the number of CD8lo thy-
mocytes (Fig. 5 a, left and right bottom; in the upper left
quadrant and Fig. 5 b), which are thought to be the thy-
mocytes that have escaped negative selection (40), was
higher in gp130F759/F759 mice, indicating that the negative
selection in gp130F759/F759 mice was impaired to some ex-
Figure 3. Flow cytometry analysis of lymphoid organs
of gp130F759/F759 mice with arthritis. Cells from the thymus
and lymph nodes of a gp130F759/F759 mouse with arthritis
and a gp130F759/WT littermate at 19 mo of age were stained
with a combination of antibodies and analyzed as described
in Materials and Methods. Dot plots of thymocytes (a and
b), total lymph node cells (c), CD4  (d and e), and CD8 
(f) lymph node cells are shown. The numbers indicate the
frequencies of the cell populations in the indicated regions
of the dot plots. These are representative data of severe
cases from the flow cytometry analysis of gp130F759/F759
mice with arthritis (n   27) and control mice (n   15) at
ages from 8 to 30 mo. The results from the gp130WT/WT
mice were similar to those from the gp130F759/WT mice.985 Atsumi et al.
tent. Then, we examined the effects of the Y759 mutation
on the peripheral clonal deletion of activated T cells. For
this study we injected a superantigen, SEB, into the mice
(41). The frequency of V 8-positive peripheral blood T
cells that had been specifically activated by SEB was de-
creased by deletion in wild-type mice injected with SEB.
On the other hand, the frequency of V 8 CD4 T cells in
the gp130F759/F759 mice was not reduced (Fig. 6 a). The fre-
quency of V 6 CD4 T cells that had not been activated
by SEB showed no reduction in either gp130F759/F759 or
wild-type mice (Fig. 6 b). These results indicated that both
thymic selection and clonal deletion of peripheral T cells
were impaired in the gp130F759/F759 mice.
Inhibitory Effect of IL-6 on Fas Ligand Expression Was Aug-
mented in gp130F759/F759 T Cells During AICD. The accu-
mulation of activated T cells in the lymphoid organs and
resistance to SEB-induced peripheral clonal deletion in
gp130F759/F759 mice suggested that AICD is impaired in
gp130F759/F759 T cells. Anti-CD3 antibody induced similar
levels of AICD ( 50%) in both gp130F759/F759 and control
T cells. In the presence of IL-6, anti-CD3–induced AICD
was inhibited and this inhibitory effect was, however,
higher in gp130F759/F759 T cells than wild-type T cells (Fig.
7 a). To identify molecules responsible for the IL-6-depen-
dent resistance to AICD, we first examined the expression
of molecules related to activation and apoptosis in the
primed T cells. The expression levels of Fas, CD25, CD69,
Bcl-2, and Bcl-X before and after the induction of AICD
were similar in wild-type and gp130F759/F759 T cells (un-
published data). The expression of FasL on gp130F759/F759 T
cells stimulated with the anti-CD3 antibody alone was sim-
ilar to wild-type T cells. Addition of IL-6 to anti-CD3
stimulation only slightly decreased the frequency of FasL-
positive cells (22–18%) in wild-type T cells (Fig. 7 b). This
negative effect of IL-6 was more evident in gp130F759/F759
T cells (20–10%) than in wild-type T cells. A similar nega-
tive effect of IL-6 on FasL expression was observed at the
transcription level (Fig. 7 c), but IL-6 had no effect on the
anti-CD3–induced upregulation of IL-2 mRNA (unpub-
lished data). To understand the molecular mechanisms of
the negative effect of IL-6 on FasL expression, we exam-
ined whether the gp130-mediated signals in gp130F759/F759
T cells were abnormal in any way.
As shown in Fig. 7 d, the IL-6–induced tyrosine-phos-
phorylation of JAK-1 and STAT-3 was prolonged, com-
pared with wild-type T cells, consistent with the previous
results observed in gp130F759/F759 fibroblasts (33). Further-
more, RT-PCR analysis revealed that IL-6 induced
SOCS-3 but not SOCS-1 mRNA in the activated
gp130F759/F759 T cells, and that this induction of SOCS-3 in
the activated gp130F759/F759 T cells was enhanced as com-
pared with gp130WT/WT T cells, probably reflecting the in-
creased STAT-3 activation (Fig. 7 e, and unpublished
data). These results raised the possibility that a prolonged
activation of STAT-3 might interfere with FasL expression.
To test this possibility, we used T cells purified from re-
constituted mice (Materials and Methods) with gp130FXXQ/
FXXQ fetal liver cells, which express gp130 mutated at the
four tyrosine residues required for gp130-mediated STAT-3
activation. As shown in Fig. 7 d, IL-6 did not induce tyro-
Figure 4. Hyperresponsiveness of
anti-CD3–stimulated thymocytes and
lymph nodes T cells in gp130F759/F759
mice (a) Thymocytes from 12-wk-
old  gp130F759/F759 mice without ar-
thritis (black circles) and their litter-
mates (white circles) were cultured
for 48 h in the presence of the indi-
cated concentrations of soluble anti-
CD3 antibody. Growth responses
were measured by 3[H]thymidine in-
corporation. Error bars indicate the
SD of duplicated cultures. Represen-
tative data from three independent
experiments are shown. The popula-
tions of the thymocytes used in this
growth assay were analyzed by flow
cytometry and dot plots are shown on
the top. (b) Lymph node cells from
8-wk-old  gp130F759/F759 mice with-
out arthritis (black circles) and their
littermates (white circles) were cultured
for 72 h in the presence of the indi-
cated concentrations of soluble anti-
CD3 antibody. Error bars indicate the
SD of duplicated cultures. Asterisks
indicate significant differences by Stu-
dent’s t test (P   0.05). Expression of
markers for memory/activated T cells
in the lymph node cells used in this
experiment is shown on the top.
Representative data from  10 inde-
pendent experiments are shown.986 Cytokine Receptor Mutation Induces Autoimmune Arthritis
sine-phosphorylation of STAT-3 in these T cells. Further-
more, the negative effect of IL-6 on AICD and FasL ex-
pression was not observed in gp130FXXQ/FXXQ T cells (Fig.
7, a–c). Taken together, these results strongly suggest that
gp130-mediated STAT-3 activation plays a negative role in
the anti-CD3–induced upregulation of FasL in activated T
cells.
Dependence of Arthritis Development on Lymphocytes. All
results described above showed that there were several ab-
normalities of immune responses in gp130F759/F759 mice,
suggesting that abnormal immunity is critically involved in
arthritis development. To clarify this issue, we investigated
whether lymphocytes are actually required for the disease.
To address this issue, we crossed gp130F759/F759 mice with
RAG-2–deficient mice to generate gp130F759/F759RAG-
2 /   double mutant animals as described in Materials
and Methods. 81% of the gp130F759/F759RAG-2 /   or
gp130F759/F759RAG-2 /  mutant mice (13 of 16) had de-
veloped arthritis (average score   SEM, 9.0   2.7) at 14
mo old. However, the gp130F759/F759/RAG-2 /  mice did
not develop arthritis (n   15), except for one case showing
only a mild, transient restriction of joints (Fig. 8). These re-
sults clearly establish that lymphocytes are essential for the
development of the arthritis in the gp130F759/F759 mice.
Discussion
 Here we showed that a point mutation of Y759 in
gp130 in mice caused spontaneous development of an age-
dependent RA-like joint disease accompanied by autoanti-
body production and T cell abnormalities, including im-
pairment of peripheral clonal deletion. Most importantly,
lymphocytes were required for disease development. The
arthritis in gp130F759/F759 mice developed in middle age and
its clinical course was chronic and progressive. It started
Figure 5.  Impaired thymic negative selection in
gp130F759/F759 mice. (a) Subpopulations of T3.70  thy-
mocytes of 8-wk-old anti-HY TCR  gp130WT/WT and
anti-HY TCR   gp130F759/F759 mice are shown in the
contour plots. Top and bottom panels show the analysis
for female and male mice, respectively. The numbers in
the quadrants are the frequencies of the subsets in the
T3.70-positive thymocytes. The total cell numbers of
thymocytes are indicated on the contour plots. (b) The
absolute cell numbers of T3.70 CD8lo thymocytes of
male anti-HY TCR  gp130WT/WT (white circle), (n   6) and anti-HY TCR  gp130F759/F759 (black circle), (n   6) mice are shown. Asterisk indicates sig-
nificant differences by Student’s t test (*P   0.05). Representative data from three independent experiments are shown.
Figure 6. Impaired peripheral clonal deletion in gp130F759/F759 mice.
SEB (100  g/mouse) was intraperitoneally injected into 6-wk-old
gp130F759/F759 (black circles) and gp130WT/WT (white circles) mice on day
0. Peripheral blood was collected on days 0, 3, 7, and 14. The cells were
stained with FITC-anti-V 8.1/8.2 (a) or -anti-V 6 (b) and APC-anti-
CD4, and analyzed by flow cytometry. The average frequencies (n   3)
of the specific V -expressing cells in the CD4  cells are plotted. The error
bars indicate SD of three mice. Asterisks indicate significant differences by
Student’s t test (*P   0.05). Representative data from three independent
experiments are shown.987 Atsumi et al.
with mild swelling and redness of the paws, and joint mo-
bility decreased thereafter. The larger joints were affected
symmetrically, and the joints eventually became ankylotic.
Radiologic analysis of the affected joints revealed the char-
acteristics of advanced human RA. Histologic examination
showed leukocytes infiltrating the joint space, hyperplasia
of the synovium with pannus formation, destruction of the
cartilage and bone, and bony ankylosis, all of which resem-
ble characteristics of human RA.
Foci of lymphocytes and plasma cells were scattered
around periarticular regions, although the degree of infil-
tration of these cells was less than in human RA. The tran-
scription of proinflammatory cytokines, in particular IL-6,
in the joints was increased. Although the infiltration of
lymphocytes was not marked around the joint tissues, the
involvement of an immunological abnormality in the
pathophysiology of the arthritis was indicated since the de-
velopment of arthritis was totally dependent on lympho-
cytes: introduction of the gp130F759/F759 mutation into
RAG-2–deficient mice did not cause arthritis. This is in
sharp contrast to the arthritis that develops in TNF AU-
rich elements-deficient mice, which is independent of lym-
phocytes (9). Consistent with this notion, production of a
variety of autoantibodies was observed in the diseased
mice. The involvement of autoantibody in RA or experi-
mentally induced arthritis model has been recently recon-
sidered (2, 7).
However, we did not observe any correlation between
the level of any of autoantibody and severity, suggesting
Figure 7. Impaired FasL expression in gp130F759/F759 T
cells in AICD. (a) Purified T cells from gp130F759/F759 mice
(black bars), their littermates (white bars) and gp130FXXQ/FXXQ
fetal liver reconstituted mice (striped bars) were activated
with anti-CD3 and anti-CD28 antibodies for 48 h and re-
cultured with IL-2 for 48 h. To induce AICD, live T cells
were collected and restimulated with immobilized anti-
CD3 antibody in the presence or absence of IL-6 for 20 h.
The frequencies of 7-AAD  dead cells were determined
by flow cytometry. Percentage of inhibition of AICD by
IL-6 was calculated by [1 – (percentage of dead cells in the
presence of IL-6)/(percentage of dead cells in the absence
of IL-6)]   100. Average values of the percentage of inhi-
bition of AICD by IL-6 from three independent experi-
ments are shown. Error bars indicate the SEM. (b) 8 h after
AICD induction, the T cells were harvested and stained
with PE-anti-FasL, and 7-AAD and analyzed with flow cytometry. White and shaded histograms indicate
the staining with anti-FasL and control antibodies, respectively. The numbers indicate the frequencies of
FasL-positive cells in 7-AAD  T cells. (c) 2 h after induction of AICD, T cells were harvested, and the
total RNA was isolated. Transcription levels of FasL mRNA were estimated by quantitative RT-PCR.
The relative transcription levels of FasL mRNA in gp130WT/WT (white bars), gp130F759/F759 (black bars), and gp130FXXQ/FXXQ (striped bars) T cells are in-
dicated. The averages from three independent experiments are shown. Error bars indicate the SD. (d) Activated T cells from gp130WT/WT and gp130F759/F759
mice and gp130FXXQ/FXXQ fetal liver reconstituted mice were stimulated with IL-6 for the indicated periods. Cells were lysed and immunoblotted with
anti-phosphotyrosine-JAK-1, anti-phosphotyrosine-STAT-3 or anti-STAT-3 antibodies. (e) Activated T cells were stimulated with IL-6 for the indi-
cated periods. Cells were harvested and the total RNA was isolated. Transcription levels of SOCS-3 mRNA were estimated by quantitative RT-PCR.
The relative transcription levels of SOCS-3 mRNA in gp130WT/WT (white circles), and gp130F759/F759 (black circles) T cells are indicated. Error bars indi-
cate the SD.
Figure 8. Lymphocytes are re-
quired for the development of
arthritis. gp130F759/F759RAG-2 / 
or  RAG-2 /  (white circles)
(n   16) and gp130F759/F759RAG-
2 /  (black circles) (n   15) mice
were examined and scored
monthly for severity of arthritis.
Data represent means   SEM.988 Cytokine Receptor Mutation Induces Autoimmune Arthritis
that B cell response may be less important than T cell re-
sponse. In line with the hypothesis that T cells play roles in
the disease we observed several abnormlities of T cells. In
the thymus of mice with arthritis, the frequency of CD4/
CD8 double-positive cells decreased and that of CD4 or
CD8 single-positive cells increased. In the lymph nodes of
gp130F759/F759 mice with arthritis, a decrease in naive CD4 
and CD8  T cells, and an increase in memory/activated
CD4  T cells were observed. These abnormal T cell popu-
lations appeared in young mice before the onset of the dis-
ease. Functionally, the in vitro hyperresponsiveness of T
cells in the thymus and lymph nodes was also observed be-
fore disease onset. The impairment of both thymic negative
selection and peripheral clonal deletion suggests that self-
tolerance is disrupted in gp130F759/F759 mice. Taken to-
gether, all results suggest that T cells may play critical roles
in the development of arthritis.
Ernst et al. reported that the knock-in mouse
gp130 STAT/ STAT displays impaired acute phase and im-
mune responses and develops severe gastrointestinal ulcer-
ation and joint disease (42). However, the joint disease that
develops in Ernst’s mouse is quite different from RA and
the disease in our gp130F759/F759 mutant mouse. The most
important difference is that the immune response is not in-
volved in the development of Ernst’s joint disease, in which
the major mechanism seems to be a proliferative disorder of
the synovial cells most likely due to enhanced ERK MAPK
activation through mutated gp130. The different pheno-
types generated in Ernst’s mice and ours could be explained
by the different mutations introduced in gp130. To make
the gp130 STAT/ STAT mouse, they deleted a large portion of
the cytoplasmic domain of gp130, including the region re-
quired for STAT-3 activation. It should be noted that the
deletion of such a large portion of gp130 may cause a wide
range of signal transduction abnormalities, not only for
STAT-3 but also for other unknown signals. On the other
hand, to make the gp130F759/F759 mouse, we introduced
point mutation at tyrosine residue Y759, which is required
for negative regulation of gp130-mediated STAT-3 activa-
tion by the SHP2-mediated signal transduction and/or
SOCS-3–mediated negative feedback (31–33); thus, our
mutant  gp130F759/F759 mouse is completely distinct from
Ernst’s gp130 mutant mouse.
Analysis using the H-Y system revealed that thymic neg-
ative selection was almost normal in the gp130F759/F759
mice, except for an increase in CD8lo cells. It has been re-
ported that substantially self-reactive clones with TCRs
that have low avidity to self-antigen escape negative selec-
tion (43). These clones are not completely anergic to self-
antigens and can respond to the antigen if it is abundant.
Thus, an intriguing hypothesis is that autoreactive T cell
clones with low-avidity TCRs for self-antigens escape the
thymic selection of gp130F759/F759 mice, and that they are
activated when the self-antigens become available due to
certain age-dependent changes in the microenvironment.
In addition to thymic selection, the clonal deletion of acti-
vated T cells in the periphery is important to maintain self-
tolerance (37, 44). After SEB injection, the number of re-
sponsive CD4  V 8  T cells in the peripheral blood was
reduced in wild-type but not gp130F759/F759 mice, demon-
strating the impairment of clonal deletion in the gp
130F759/F759 mice in vivo. Several reports indicated that
IL-6 has antiapoptotic effects on naive but not activated T
cells (45–47), and the inhibition of AICD and downregula-
tion of FasL by IL-6 has been reported previously (48).
IL-6 only slightly inhibited AICD and anti-CD3–induced
upregulation of FasL in activated wild-type T cells. Impor-
tantly, this negative effect on FasL expression was enhanced
in gp130F759/F759 compared with wild-type T cells, whereas
IL-6 had no effect on gp130FXXQ/FXXQ T cells. Because
IL-6–induced activation of STAT-3 was prolonged in
gp130F759/F759 T cells, while IL-6 failed to activate STAT-3
in gp130FXXQ/FXXQ T cells, it is most likely that STAT-3 has
a suppressive effect on the anti-CD3–induced upregulation
of FasL in activated T cells.
It is also possible that unknown signals generated from
any one of the four tyrosine residues of gp130 that are re-
quired for STAT-3 activation may be involved in the sup-
pression of FasL expression. Alternatively SOCS-3 may in-
terfere T cell receptor-mediated signaling involved in FasL
induction since IL-6–mediated SOCS-3 induction was en-
hanced in gp130F759/F759 T cells as compared with wild-
type T cells. In any case, it is evident that gp130F759/F759 T
cells showed suppressed FasL expression in the presence of
IL-6 in a manner dependent on the tyrosine residues of
gp130 that are required for STAT-3 activation. Regardless
of the precise mechanism, it is reasonable to speculate that
resistance of T cells in gp130F759/F759 mice to clonal dele-
tion in vivo is also involved in the development of autoim-
mune disease by the breakdown of self-tolerance. An in-
triguing possibility is that very mild impairment of both
central and peripheral tolerance is required for the devel-
opment of age-dependent autoimmune disease in gp
130F759/F759 mice. Study of the signal transduction path-
ways that are initiated through gp130 has shown that a sin-
gle cytokine receptor can simultaneously transduce multi-
ple, contradictory signals, leading to a variety of responses,
such as growth and differentiation, and that the balance of
the contradictory signals determines the biological output
of a given cytokine (24).
The fact that selective disruption of gp130 signals depen-
dent on Y759, which augments gp130-mediated STAT-3
activation (33), resulted in joint disease with autoimmu-
nity, provides an intriguing, unique case where the disrup-
tion of the balance of signals transduced from one cytokine
receptor may cause autoimmune disease. It is also possible
that lack of negative feedback mechanisms through
SOCS-3 may be involved in enhanced STAT-3 activation
through gp130 and the generation of the disease, since
Y759 is shown to be required for the negative effect of
SOCS-3 (31, 32). Another possibility is that enhanced in-
duction of SOCS-3 through gp130 may modulate signaling
by other cytokines.
Although we clearly showed that lymphocytes are re-
quired for disease development, it is also possible that ab-
normal gp130-mediated signals generated in other cells989 Atsumi et al.
function with lymphocytes to cause diseases because gp130
is expressed in a variety of cells, including macrophages,
granulocytes, dendritic cells, fibroblasts, epithelial cells, en-
dothelial cells, synovial cells, and osteoclasts. Among them,
granulocytes infiltrating in the synovium may play an im-
portant role in the course of arthritis.
Taken together, our results show that the gp130F759/F759
mutant mouse is a new animal model of autoimmune ar-
thritis and is unique in demonstrating that a point mutation
of a cytokine receptor can trigger complicated immunolog-
ical and inflammatory processes, leading to the generation
of autoimmune disease.
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